Methylprednisolone Completed Phase 2 Trials for Nephritis, Lupus Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02260934Rituximab and Belimumab for Lupus Nephritis
NCT00423098Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare